| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/20/2007 | CA2433518C Method for producing the anticholinergic tiotropium bromide |
| 03/20/2007 | CA2278509C Production method of optically active imidazole compound, synthetic intermediate therefor and production method thereof |
| 03/15/2007 | WO2007030023A1 A medical composition for treating wounds |
| 03/15/2007 | WO2007029730A1 Amino acid composition for prevention or treatment of senile anemia |
| 03/15/2007 | WO2007029642A1 Remedy for osteoporosis with the use of retinoid x receptor-related compound |
| 03/15/2007 | WO2007029629A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
| 03/15/2007 | WO2007029587A1 β SECRETASE INHIBITOR |
| 03/15/2007 | WO2007029345A1 Tyrosinase activity inhibitor |
| 03/15/2007 | WO2007028999A1 Thiazole compounds and their use as pgd2 antagonists |
| 03/15/2007 | WO2007028212A1 Noggin and chimeric molecules thereof |
| 03/15/2007 | US20070061921 Transgenic cells |
| 03/15/2007 | US20070060647 Gene expression regulating agent |
| 03/15/2007 | US20070060595 Novel fused heterocyclic compound and use thereof |
| 03/15/2007 | US20070060591 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections |
| 03/15/2007 | US20070060574 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors |
| 03/15/2007 | US20070060568 5HT2c receptor modulators |
| 03/15/2007 | US20070060553 3-Nitrogen-6,7-dioxygen steroids and uses related thereto |
| 03/15/2007 | US20070060541 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060538 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/15/2007 | US20070060531 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 03/15/2007 | US20070060521 Inhibition of STAT3 signal transduction for human cancer therapy |
| 03/15/2007 | US20070060505 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060504 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060503 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060498 2' and 3'-Prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides provide superior results against flaviviruses and pestiviruses, including hepatitis C virus and viruses that replicate through an RNA dependent RNA reverse transcriptase; administering interferons as second antivirus agent |
| 03/15/2007 | US20070059836 Genetic engineering; preventing the proliferation of neoplastic cells; cancer; |
| 03/15/2007 | US20070059797 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 03/15/2007 | US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 03/15/2007 | US20070059684 Method of identifying an antiviral agent |
| 03/15/2007 | US20070059400 Composition containing ground lotus and/or lotus extract and lactic acid bacterium |
| 03/15/2007 | US20070059338 Compositions and techniques for localized therapy |
| 03/15/2007 | US20070059323 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof |
| 03/15/2007 | CA2621774A1 A medical composition for treating wounds |
| 03/14/2007 | EP1762611A1 Nucleic acid/enzyme complex |
| 03/14/2007 | EP1762610A1 Truncated dance, dance complex and method of using these |
| 03/14/2007 | EP1762574A2 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 03/14/2007 | EP1762567A1 Pyrazole derivatives for treating HIV |
| 03/14/2007 | EP1762236A2 Formulations of alpha adrenergic receptor antagonists and their uses |
| 03/14/2007 | EP1762234A1 Ampk activator |
| 03/14/2007 | EP1761560A1 Peptide-based compounds |
| 03/14/2007 | EP1761515A1 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 03/14/2007 | EP1761253A2 Hyaluronic acid in the enhancement of lens regeneration |
| 03/14/2007 | EP1694318B1 (s)-2-n-propylamino-5-hydroxytetralin as a d3-agonist |
| 03/14/2007 | EP1515949B1 Mitotic kinesin inhibitors |
| 03/14/2007 | EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 03/14/2007 | EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same |
| 03/14/2007 | EP1406897B1 Compounds |
| 03/14/2007 | EP1399152B1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester |
| 03/14/2007 | EP1397681B1 Method for identification of agents for the treatment of diabetes |
| 03/14/2007 | EP1397156B1 Oral administration of parathyroid hormone and calcitonin |
| 03/14/2007 | EP1305434B1 A human disintegrin protein |
| 03/14/2007 | EP1259262B1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 03/14/2007 | EP1254180B1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 03/14/2007 | EP1253919A4 Method and compositions for treating an inflammatory disease |
| 03/14/2007 | EP1216031B1 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 03/14/2007 | EP1212068A4 Method of enhancing the efficacy of anti-tumor agents |
| 03/14/2007 | EP1189623B1 Method and composition for inhibiting cardiovascular cell proliferation |
| 03/14/2007 | EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 03/14/2007 | EP1112057B1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 03/14/2007 | EP1071411B1 Topical immunostimulation to induce langerhans cell migration |
| 03/14/2007 | EP0998471B1 Substituted heterocyclic compounds, method for preparing and compositions containing same |
| 03/14/2007 | EP0966302B1 Methods of therapeutic administration of anti-cd40l compounds |
| 03/14/2007 | CN1930180A L-saccharide glucose lipid a analogue |
| 03/14/2007 | CN1930151A Novel indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug each comprising the same |
| 03/14/2007 | CN1930145A Cycloalkanopyridine derivative |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1930123A Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 03/14/2007 | CN1929858A Use of factor VIIa equivalents for treating trauma |
| 03/14/2007 | CN1929829A (S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist |
| 03/14/2007 | CN1928113A Function and application of RhoA/ROK alpha signal conduction path in blood vessel adventitia reconstruction |
| 03/14/2007 | CN1928112A Expression of VEGF I type receptor on blood vessel adventitia fibroblast |
| 03/14/2007 | CN1927373A Health care traditional Chinese medicine formulation for conditioning functional activities of qi |
| 03/14/2007 | CN1927302A Medicament for animals with heat clearing and detoxicating, detumescence and pus drainage functions and preparing method thereof |
| 03/14/2007 | CN1927272A Medicament for animals with heat clearing and detoxicating, detumescence and obstruction removing functions and preparing method thereof |
| 03/14/2007 | CN1304567C Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC |
| 03/14/2007 | CN1304559C Oncolytic microorganism expressing heat shock protein and its application |
| 03/14/2007 | CN1304424C Compounds with growth hormone releasing properties |
| 03/14/2007 | CN1304421C Peptides having affinity for the GP 120 viral protein and use thereof |
| 03/14/2007 | CN1304418C Nuclear factor-K B P65 subunit antagonistic peptide and its use |
| 03/14/2007 | CN1304415C Pyrane derivatives as both ACE- and NEP- inhibitors |
| 03/14/2007 | CN1304390C Novel gamma secretase inhibitors |
| 03/14/2007 | CN1304389C Piperidine derivatives useful as CCR5 antagonists |
| 03/14/2007 | CN1304383C Benzothiazole derivatives |
| 03/14/2007 | CN1304380C Benzo[alpha]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II |
| 03/14/2007 | CN1304379C Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/14/2007 | CN1304378C Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304375C Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions |
| 03/14/2007 | CN1304374C Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition |
| 03/14/2007 | CN1304372C Tri-substituted phenyl derivates useful as PDE IV inhibitors |
| 03/14/2007 | CN1304058C Water soluble paclitaxel prodrugs |
| 03/14/2007 | CN1304051C PSGL-1 regulator |
| 03/14/2007 | CN1304047C Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 03/14/2007 | CN1304008C Medical compsns. |
| 03/14/2007 | CN1304005C Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound |
| 03/14/2007 | CN1303999C Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same |
| 03/13/2007 | US7189878 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 03/13/2007 | US7189870 Cardiovascular disorders; antiinflammatory agents |